Veröffentlichungen



Risikofaktoren und Prognose


2014

Obi, N., Gornyk, D., Heinz, J., Vrieling, A., Seibold, P., Chang-Claude, J., and Flesch-Janys, D.
Determinants of newly diagnosed comorbidities among breast cancer survivors.
J Cancer Surviv. 2014; 8:384-393.

Seibold, P., Vrieling, A., Johnson, T. S., Buck, K., Behrens, S., Kaaks, R., Linseisen, J., Obi, N., Heinz, J., Flesch-Janys, D., and Chang-Claude, J.
Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
Int J Cancer 2014; 135:923-933.

Seibold, P., Vrieling, A., Heinz, J., Obi, N., Sinn, H. P., Flesch-Janys, D., and Chang-Claude, J.
Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort - Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake.
Cancer Epidemiol 2014; 38:419-426.

Vrieling, A., Seibold, P., Johnson, T. S., Heinz, J., Obi, N., Kaaks, R., Flesch-Janys, D., and Chang-Claude, J.
Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Int J Cancer 2014; 134:2972-2983.

Schmidt, M. E., Chang-Claude, J., Seibold, P., Vrieling, A., Heinz, J., Flesch-Janys, D., and Steindorf, K.
Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study.
Psychooncology. 2014;


2013

Buck, K., Hug, S., Seibold, P., Ferschke, I., Altevogt, P., Sohn, C., Schneeweiss, A., Burwinkel, B., Jager, D., Flesch-Janys, D., Chang-Claude, J., and Marme, F.
CD24 polymorphisms in breast cancer: impact on prognosis and risk.
Breast Cancer Res Treat 2013; 137:927-937.

Eichelser, C., Flesch-Janys, D., Chang-Claude, J., Pantel, K., and Schwarzenbach, H.
Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.
Clin Chem. 2013; 59:1489-1496.

Nickels, S., Vrieling, A., Seibold, P., Heinz, J., Obi, N., Flesch-Janys, D., and Chang-Claude, J.
Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.
PLoS One 2013; 8:e75088-

Popanda, O., Seibold, P., Nikolov, I., Oakes, C. C., Burwinkel, B., Hausmann, S., Flesch-Janys, D., Plass, C., Chang-Claude, J., and Schmezer, P.
Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk.
Int J Cancer 2013; 132:55-62.

Schmidt, M. E., Chang-Claude, J., Vrieling, A., Seibold, P., Heinz, J., Obi, N., Flesch-Janys, D., and Steindorf, K.
Association of pre-diagnosis physical activity with recurrence and mortality among women with breast cancer.
Int J Cancer 2013; 133:1431-1440.

Seibold, P., Hall, P., Schoof, N., Nevanlinna, H., Heikkinen, T., Benner, A., Liu, J., Schmezer, P., Popanda, O., Flesch-Janys, D., and Chang-Claude, J.
Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients--potential differential effects by radiotherapy?
Breast 2013; 22:817-823.

Vrieling, A., Buck, K., Seibold, P., Heinz, J., Obi, N., Flesch-Janys, D., and Chang-Claude, J.
Dietary patterns and survival in German postmenopausal breast cancer survivors.
Br J Cancer 2013; 108:188-192.


2012

Hein, R., Abbas, S., Seibold, P., Salazar, R., Flesch-Janys, D., and Chang-Claude, J.
Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
Breast Cancer Res Treat 2012; 131:653-661.

Schmidt, M. E., Chang-Claude, J., Vrieling, A., Heinz, J., Flesch-Janys, D., and Steindorf, K.
Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern.
J Cancer Surviv. 2012; 6:11-19.

Vrieling, A., Buck, K., Heinz, J., Obi, N., Benner, A., Flesch-Janys, D., and Chang-Claude, J.
Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study.
Breast Cancer Res Treat 2012; 136:195-207.

Zaineddin, A. K., Vrieling, A., Buck, K., Becker, S., Linseisen, J., Flesch-Janys, D., Kaaks, R., and Chang-Claude, J.
Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
Int J Cancer 2012; 130:1401-1410.

Zaineddin, A. K., Buck, K., Vrieling, A., Heinz, J., Flesch-Janys, D., Linseisen, J., and Chang-Claude, J.
The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case-control study.
Nutr Cancer 2012; 64:652-665.


2011

Barnes, B. B., Steindorf, K., Hein, R., Flesch-Janys, D., and Chang-Claude, J.
Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.
Cancer Epidemiol 2011; 35:345-352.

Buck K, Vrieling A, Flesch-Janys D, Chang-Claude J.
Dietary patterns and the risk of postmenopausal breast cancer in a German case-control study.
Cancer Causes Control 2011 February;22(2):273-82.

Buck, K., Zaineddin, A. K., Vrieling, A., Heinz, J., Linseisen, J., Flesch-Janys, D., and Chang-Claude, J.
Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer.
Br J Cancer 2011; 105:1151-1157.

Buck, K., Vrieling, A., Zaineddin, A. K., Becker, S., Husing, A., Kaaks, R., Linseisen, J., Flesch-Janys, D., and Chang-Claude, J
Serum enterolactone and prognosis of postmenopausal breast cancer.
J Clin Oncol 2011; 29:3730-3738.

Li J, Seibold P, Chang-Claude J, Flesch-Janys D, Liu J, Czene K, Humphreys K, Hall P.
Coffee consumption modifies risk of estrogen-receptor negative breast cancer.
Breast Cancer Res. 2011;13:R49.

Liedtke S, Schmidt ME, Becker S, Kaaks R, Zaineddin AK, Buck K, Flesch-Janys D, Wahrendorf J, Chang-Claude J, Steindorf K.
Physical activity and endogenous sex hormones in postmenopausal women: to what extent are observed associations confounded or modified by BMI?.
Cancer Causes Control 2011 January;22(1):81-9.

Seibold, P., Hein, R., Schmezer, P., Hall, P., Liu, J., Dahmen, N., Flesch-Janys, D., Popanda, O., and Chang-Claude, J.
Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk.
Int J Cancer 2011; 129:1467-1476.

Vrieling, A., Hein, R., Abbas, S., Schneeweiss, A., Flesch-Janys, D., and Chang-Claude, J.
Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
Breast Cancer Res 2011; 13:R74-.

Zaineddin AK, Vrieling A, Buck K et al.
Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and HER2 receptor status.
Int J Cancer. 2011.



2010

Barnes BB, Steindorf K, Hein R, Flesch-Janys D, Chang-Claude J.
Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.
Cancer Epidemiol 2010 December 13.

Hentschel S, Heinz J, Schmid-Hopfner S, Obi N, Vettorazzi E, Chang-Claude J, Flesch-Janys D.
The impact of menopausal hormone therapy on the incidence of different breast cancer types--data from the Cancer Registry Hamburg 1991-2006.
Cancer Epidemiol 2010 October;34(5):639-43.

Seibold P, Hein R, Schmezer P, Hall P, Liu J, Dahmen N, Flesch-Janys D, Popanda O, Chang-Claude J.
Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk.
Int J Cancer 2010 November 12.

Steindorf K, Chang-Claude J, Flesch-Janys D, Schmidt ME.
Determinants of sports, cycling, walking and overall leisure-time physical activity among postmenopausal women in Germany.
Public Health Nutr 2010 November;13(11):1905-14.

MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy
Int J Cancer. 2010 Jun 15; 126(12):2935-46.

MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women
Breast Cancer Res Treat. 2010 Apr;120(3):727-36.

MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism
Breast Cancer Res Treat. 2010 Apr;120(3):737-44.


2009

Abbas S, Brauch H, Chang-Claude J, Dünnebier T, Flesch-Janys D, Hamann U, Hein R, Justenhoven C, Salazar R.
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy
Int J Cancer. 2009 Sep 8.

The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women
Breast Cancer Res Treat. 2009 Aug 12.

The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism
Breast Cancer Res Treat. 2009 Aug 12.

Schmidt ME, Chang-Claude J, Slanger T, Obi N, Flesch-Janys D, Steindorf K.
Physical activity and postmenopausal breast cancer: effect modification by other breast cancer risk factors
Methods Inf Med. 2009;48(5):444-50.

Barnes BB, Chang-Claude J, Flesch-Janys D, Kinscherf R, Schmidt M, Slanger T, Bonaterra G, Steindorf K.
Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status
Cancer Causes Control. 2009 Jul 12.

MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women
Breast Cancer Res Treat. 2010 Jan;119(2):463-74.

Obi N, Chang-Claude J, Berger J, Braendle W, Slanger T, Schmidt M, Steindorf K, Ahrens W, Flesch-Janys D.
The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study
Cancer Epidemiol Biomarkers Prev. 2009; 18(8). August 2009

Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D.
Menopausal Hormone Therapy and Risk of Clinical Breast Cancer Subtypes
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96


2008

Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Berger J, Chang-Claude J.
Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy
Int J Cancer. 2008 Aug 15;123(4):933-41.

Schmidt ME, Steindorf K, Mutschelknauss E, Slanger T, Kropp S, Obi N, Flesch-Janys D, Chang-Claude J.
Physical activity and postmenopausal breast cancer: effect modification by breast cancer subtypes and effective periods in life
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3402-10. Epub 2008 Nov 24.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J
The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin d status
Cancer Epidemiol Biomarkers Prev 2008; 17(6):1339-1343.

Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J
Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk
Breast Cancer Res 2008; 10(2):R31.


2007

Kropp, S., Terboven, T., Hedicke, J., Mutschelknauss, E. J., Slanger, T., Braendle, W., Berger, J., Chang-Claude, J., and Flesch-Janys, D.
Good agreement between physician reports and questionnaire hormone therapy data in a German case-control study
Journal of Clinical Epidemiology 2007; Vol.60 (12):1280-1287

Slanger, T., Mutschelknaus, E. J., Kropp, S., Braendle, W., Flesch-Janys, D., and Chang-Claude, J.
Test-retest reliability of self-reported reproductive and lifestyle data in the context of a German case-control study on breast cancer and postmenopausal hormone therapy
Annals of Epidemiology 2007 Dec;17(12):993-8. Epub 2007 Sep 14

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss E, Flesch-Janys D, Chang-Claude J
Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer - results of a large case-control study.
Carcinogenesis 2007.


2004

Flesch-Janys D, Kropp S, Terboven T, Hedicke J, Mutschelknauss EJ, Slanger T, Braendle W, Berger J, Chang-Claude J.
Validation study on self-reported use and physician report of hormone therapy.
Journal für Menopause 11[2], 37. 2004


2002

Braendle, W., Berger, J., Flesch-Janys, D., Hentschel, S., and Chang-Claude, J
Presentation of the first German epidemiologic study on HRT and breast cancer
Climacteric ,2002; 5 Sup 1:118-118.

Braendle W, Berger J, Flesch-Janys D, Hentschel S, Bastert G
Vorstellung der ersten deutschen epidemiologischen Studie zu HRT und Mammakarzinom
J Menopause 2002; 9(2):29-38.

Flesch-Janys D, Braendle W, Berger J, Hentschel S, Mutschelknauss EJ
MARIE-Studie startet in Hamburg.
Hamburger Ärzteblatt 2002.

Flesch-Janys D, Braendle W:
Deutsche epidemiologische Studie zu HRT und Mammakarzinom.
Gyno-Panorama 2002;(3):17-24.



Genetik


2015

Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, Yarnold J, Talbot CJ, Imai T, Azria D, Koch CA, Dunning AM, Burnet N, Bliss JM, Symonds RP, Rattay T, Suga T, Kerns SL, Bourgier C, Vallis KA, Sautter-Bihl ML, Claßen J, Debus J, Schnabel T, Rosenstein BS, Wenz F, West CM, Popanda O, Chang-Claude J.
XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.
Int J Radiat Oncol Biol Phys. 2015 Apr 11. pii: S0360-3016(15)00409-5. doi: 10.1016/j.ijrobp.2015.04.011. [Epub ahead of print]


2013

Justenhoven C, Obazee O, Winter S, Rabstein S, Lotz A, Harth V, Pesch B, Brüning T, Baisch C, Hartikainen JM, Mannermaa A, Kosma VM, Kataja V, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Fasching PA, Beckmann M, Ekici AB, Hein A, Hall P, Li J, Chang-Claude J, Flesch-Janys D, Seibold P, Rudolph A, Hamann U, Ko YD, Brauch H.
The UGT1A6_19_GG genotype is a breast cancer risk factor.
Front Genet. 2013 Jun 11;4:104. doi: 10.3389/fgene.2013.00104. eCollection 2013.

Seibold P, Hall P, Schoof N, Nevanlinna H, Heikkinen T, Benner A, Liu J, Schmezer P, Popanda O, Flesch-Janys D, Chang-Claude J.
Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients--potential differential effects by radiotherapy?
Breast. 2013 Oct;22(5):817-23. doi: 10.1016/j.breast.2013.02.008. Epub 2013 Mar 13.

Obazee O, Justenhoven C, Winter S, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Hannelius U, Li J, Humphreys K, Hall P, Giles G, Severi G, Baglietto L, Southey M, Rabstein S, Harth V, Lotz A, Pesch B, Brüning T, Baisch C, Ko YD, Hamann U, Brauch H.
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.
Breast Cancer Res Treat. 2013 Apr;138(2):543-8. doi: 10.1007/s10549-013-2448-7. Epub 2013 Feb 21.

Hein R, Flesch-Janys D, Dahmen N, Beckmann L, Lindström S, Schoof N, Czene K, Mittelstraß K, Illig T, Seibold P, Behrens S, Humphreys K, Li J, Liu J, Olson JE, Wang X, Hankinson SE, Truong T, Menegaux F, Dos Santos Silva I, Johnson N; GENICA Network, Chen ST, Yu JC, Ziogas A, Kataja V, Kosma VM, Mannermaa A, Anton-Culver H, Shen CY, Brauch H, Peto J, Guénel P, Kraft P, Couch FJ, Easton DF, Hall P, Chang-Claude J.
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication.
Breast Cancer Res Treat. 2013 Apr;138(2):529-42. doi: 10.1007/s10549-013-2443-z. Epub 2013 Feb 20.

Buck K, Hug S, Seibold P, Ferschke I, Altevogt P, Sohn C, Schneeweiss A, Burwinkel B, Jäger D, Flesch-Janys D, Chang-Claude J, Marmé F.
CD24 polymorphisms in breast cancer: impact on prognosis and risk.
Breast Cancer Res Treat. 2013 Feb;137(3):927-37. doi: 10.1007/s10549-012-2325-9. Epub 2013 Jan 13.




Im Folgenden sind ausgewählte Studien des Breast Cancer Association Consortiums aufgelistet, in welches die MARIE-Studie eingegliedert ist. Das Breast Cancer Association Consortiums ist ein internationaler Zusammenschluss von Forschern, welche das gemeinsame Ziel haben Gene zu identifizieren, die das Brustkrebsrisiko beeinflussen.


Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Czene K, Darabi H, Eriksson M, Peto J, Dos-Santos-Silva I, Dudbridge F, Johnson N, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Couch FJ, Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval C, van Limbergen E, Kristensen V, Grenaker Alnæs G, Nord S, Borresen-Dale AL, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova NV, Antonenkova NN, Dörk T, Anton-Culver H, Neuhausen SL, Ziogas A, Bernstein L, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox A, Cross SS, Reed MW, Khusnutdinova E, Bermisheva M, Prokofyeva D, Takhirova Z, Meindl A, Schmutzler RK, Sutter C, Yang R, Schürmann P, Bremer M, Christiansen H, Park-Simon TW, Hillemanns P, Guénel P, Truong T, Menegaux F, Sanchez M, Radice P, Peterlongo P, Manoukian S, Pensotti V, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Brauch H, Brüning T, Ko YD, Sigurdson AJ, Doody MM, Hamann U, Torres D, Ulmer HU, Försti A, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Andrulis IL, Knight JA, Glendon G, Marie Mulligan A, Chenevix-Trench G, Balleine R, Giles GG, Milne RL, McLean C, Lindblom A, Margolin S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Eilber U, Wang-Gohrke S, Hooning MJ, Hollestelle A, van den Ouweland AM, Koppert LB, Carpenter J, Clarke C, Scott R, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Brenner H, Arndt V, Stegmaier C, Karina Dieffenbach A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Offit K, Vijai J, Robson M, Rau-Murthy R, Dwek M, Swann R, Annie Perkins K, Goldberg MS, Labrèche F, Dumont M, Eccles DM, Tapper WJ, Rafiq S, John EM, Whittemore AS, Slager S, Yannoukakos D, Toland AE, Yao S, Zheng W, Halverson SL, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Simard J, Hall P, Easton DF, Garcia-Closas M.
Prediction of breast cancer risk based on profiling with common genetic variants.
J Natl Cancer Inst. 2015 Apr 8;107(5). pii: djv036. doi: 10.1093/jnci/djv036. Print 2015 May.

Guo Q, Schmidt MK, Kraft P, Canisius S, Chen C, Khan S, Tyrer J, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, Kar S, Beesley J, Dunning AM, Shah M, Czene K, Darabi H, Eriksson M, Lambrechts D, Weltens C, Leunen K, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Blomqvist C, Aittomäki K, Fagerholm R, Muranen TA, Couch FJ, Olson JE, Vachon C, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Broeks A, Hogervorst FB, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Cox A, Cross SS, Reed MW, Giles GG, Milne RL, McLean C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning MJ, Hollestelle A, Martens JW, van den Ouweland AM, Marme F, Schneeweiss A, Yang R, Burwinkel B, Figueroa J, Chanock SJ, Lissowska J, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Brenner H, Dieffenbach AK, Arndt V, Holleczek B, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Li J, Brand JS, Humphreys K, Devilee P, Tollenaar RA, Seynaeve C, Radice P, Peterlongo P, Bonanni B, Mariani P, Fasching PA, Beckmann MW, Hein A, Ekici AB, Chenevix-Trench G, Balleine R; kConFab Investigators, Phillips KA, Benitez J, Zamora MP, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Hamann U, Kabisch M, Ulmer HU, Rüdiger T, Margolin S, Kristensen V, Nord S, Evans DG, Abraham JE, Earl HM, Hiller L, Dunn JA, Bowden S, Berg C, Campa D, Diver WR, Gapstur SM, Gaudet MM, Hankinson SE, Hoover RN, Hüsing A, Kaaks R, Machiela MJ, Willett W, Barrdahl M, Canzian F, Chin SF, Caldas C, Hunter DJ, Lindstrom S, García-Closas M, Hall P, Easton DF, Eccles DM, Rahman N, Nevanlinna H, Pharoah PD.
Identification of novel genetic markers of breast cancer survival.
J Natl Cancer Inst. 2015 Apr 18;107(5). pii: djv081. doi: 10.1093/jnci/djv081. Print 2015 May.

Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ, Maranian MJ, Bolla MK, Wang Q, Shah M, Perkins BJ, Czene K, Eriksson M, Darabi H, Brand JS, Bojesen SE, Nordestgaard BG, Flyger H, Nielsen SF, Rahman N, Turnbull C; BOCS, Fletcher O, Peto J, Gibson L, dos-Santos-Silva I, Chang-Claude J, Flesch-Janys D, Rudolph A, Eilber U, Behrens S, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Khan S, Aaltonen K, Ahsan H, Kibriya MG, Whittemore AS, John EM, Malone KE, Gammon MD, Santella RM, Ursin G, Makalic E, Schmidt DF, Casey G, Hunter DJ, Gapstur SM, Gaudet MM, Diver WR, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Berg CD, Chanock SJ, Figueroa J, Hoover RN, Lambrechts D, Neven P, Wildiers H, van Limbergen E, Schmidt MK, Broeks A, Verhoef S, Cornelissen S, Couch FJ, Olson JE, Hallberg E, Vachon C, Waisfisz Q, Meijers-Heijboer H, Adank MA, van der Luijt RB, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park SK, Yoo KY, Matsuo K, Ito H, Iwata H, Tajima K, Guénel P, Truong T, Mulot C, Sanchez M, Burwinkel B, Marme F, Surowy H, Sohn C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, González-Neira A, Benitez J, Zamora MP, Perez JI, Shu XO, Lu W, Gao YT, Cai H, Cox A, Cross SS, Reed MW, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N; kConFab Investigators; AOCS Group, Lindblom A, Margolin S, Teo SH, Yip CH, Taib NA, Tan GH, Hooning MJ, Hollestelle A, Martens JW, Collée JM, Blot W, Signorello LB, Cai Q, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Shen CY, Hsiung CN, Wu PE, Hou MF, Kristensen VN, Nord S, Alnaes GI; NBCS, Giles GG, Milne RL, McLean C, Canzian F, Trichopoulos D, Peeters P, Lund E, Sund M, Khaw KT, Gunter MJ, Palli D, Mortensen LM, Dossus L, Huerta JM, Meindl A, Schmutzler RK, Sutter C, Yang R, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Chia KS, Chan CW, Fasching PA, Hein A, Beckmann MW, Haeberle L, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Ashworth A, Orr N, Schoemaker MJ, Swerdlow AJ, Brinton L, Garcia-Closas M, Zheng W, Halverson SL, Shrubsole M, Long J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Hamann U, Brüning T; GENICA Network, Radice P, Peterlongo P, Manoukian S, Bernard L, Bogdanova NV, Dörk T, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RA, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska K, Huzarski T, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Kabisch M, Torres D, Neuhausen SL, Anton-Culver H, Luccarini C, Baynes C, Ahmed S, Healey CS, Tessier DC, Vincent D, Bacot F, Pita G, Alonso MR, Álvarez N, Herrero D, Simard J, Pharoah PP, Kraft P, Dunning AM, Chenevix-Trench G, Hall P, Easton DF.
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
Nat Genet. 2015 Apr;47(4):373-80. doi: 10.1038/ng.3242. Epub 2015 Mar 9.

Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N; Breast and Ovarian Cancer Susceptibility Collaboration, Fletcher O, Peto J, Gibson L, Dos Santos Silva I, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Czene K, Irwanto A, Liu J, Waisfisz Q, Meijers-Heijboer H, Adank M; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), van der Luijt RB, Hein R, Dahmen N, Beckman L, Meindl A, Schmutzler RK, Müller-Myhsok B, Lichtner P, Hopper JL, Southey MC, Makalic E, Schmidt DF, Uitterlinden AG, Hofman A, Hunter DJ, Chanock SJ, Vincent D, Bacot F, Tessier DC, Canisius S, Wessels LF, Haiman CA, Shah M, Luben R, Brown J, Luccarini C, Schoof N, Humphreys K, Li J, Nordestgaard BG, Nielsen SF, Flyger H, Couch FJ, Wang X, Vachon C, Stevens KN, Lambrechts D, Moisse M, Paridaens R, Christiaens MR, Rudolph A, Nickels S, Flesch-Janys D, Johnson N, Aitken Z, Aaltonen K, Heikkinen T, Broeks A, Veer LJ, van der Schoot CE, Guénel P, Truong T, Laurent-Puig P, Menegaux F, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Zamora MP, Perez JI, Pita G, Alonso MR, Cox A, Brock IW, Cross SS, Reed MW, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Henderson BE, Schumacher F, Le Marchand L, Andrulis IL, Knight JA, Glendon G, Mulligan AM; kConFab Investigators; Australian Ovarian Cancer Study Group, Lindblom A, Margolin S, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Bui QM, Stone J, Dite GS, Apicella C, Tsimiklis H, Giles GG, Severi G, Baglietto L, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Müller H, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Jones M, Figueroa J, Lissowska J, Brinton L, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Hamann U, Brüning T; GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, Radice P, Peterlongo P, Manoukian S, Bonanni B, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Jakubowska A, Lubinski J, Jaworska K, Durda K, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Bogdanova NV, Antonenkova NN, Dörk T, Kristensen VN, Anton-Culver H, Slager S, Toland AE, Edge S, Fostira F, Kang D, Yoo KY, Noh DY, Matsuo K, Ito H, Iwata H, Sueta A, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Shu XO, Lu W, Gao YT, Cai H, Teo SH, Yip CH, Phuah SY, Cornes BK, Hartman M, Miao H, Lim WY, Sng JH, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Shen CY, Hsiung CN, Wu PE, Ding SL, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Blot WJ, Signorello LB, Cai Q, Zheng W, Deming-Halverson S, Shrubsole M, Long J, Simard J, Garcia-Closas M, Pharoah PD, Chenevix-Trench G, Dunning AM, Benitez J, Easton DF.
Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Nat Genet. 2013 Apr;45(4):353-61, 361e1-2. doi: 10.1038/ng.2563.


Weitere Publikationen des Breast Cancer Association Consortiums:

Link zur BCAC-Internetseite



zum Seitenanfang